Thompson Investment Management, Inc. Amgen Inc Transaction History

Thompson Investment Management, Inc.

$677 Million
Q3 2024

A detailed history of Thompson Investment Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 18,853 shares of AMGN stock, worth $4.97 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

18,853

Previous 18,753 0.53%

Holding current value

$4.97 Million

Previous $5.86 Million 3.67%

% of portfolio

0.9%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $30,938 - $33,738	100 Added 0.53%	18,853 $6.07 Million
Q2 2024 Jul 08, 2024	BUY	$262.75 - $319.31 $120,339 - $146,243	458 Added 2.5%	18,753 $5.86 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $19,089 - $23,043	-71 Reduced 0.39%	18,295 $5.2 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $62,646 - $70,672	-245 Reduced 1.32%	18,366 $5.29 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $453,261 - $562,736	-2,073 Reduced 10.02%	18,611 $5 Million
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $210,841 - $249,316	984 Added 4.99%	20,684 $4.59 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $117,185 - $142,828	519 Added 2.71%	19,700 $4.76 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $39,393 - $50,053	-172 Reduced 0.89%	19,181 $5.04 Million
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $10,100 - $11,391	-45 Reduced 0.23%	19,353 $4.36 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $318,841 - $354,814	-1,382 Reduced 6.65%	19,398 $4.72 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $102,399 - $113,280	-467 Reduced 2.2%	20,780 $5.03 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $251,782 - $288,141	1,266 Added 6.34%	21,247 $4.78 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $168,542 - $197,467	794 Added 4.14%	19,981 $4.25 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $198,776 - $220,528	851 Added 4.64%	19,187 $4.68 Million
Q1 2021 Apr 07, 2021	BUY	$221.91 - $258.6 $21,969 - $25,601	99 Added 0.54%	18,336 $4.56 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $138,266 - $164,651	639 Added 3.63%	18,237 $4.19 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $139,382 - $155,004	-594 Reduced 3.27%	17,598 $4.47 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $273,769 - $335,952	-1,384 Reduced 7.07%	18,192 $4.29 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $282,107 - $374,151	-1,548 Reduced 7.33%	19,576 $3.97 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $192,994 - $248,064	-1,020 Reduced 4.61%	21,124 $5.09 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $43,005 - $51,529	247 Added 1.13%	22,144 $4.29 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $7,168 - $8,402	43 Added 0.2%	21,897 $4.04 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $22,789 - $25,688	-126 Reduced 0.57%	21,854 $4.15 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $1.01 Million - $1.18 Million	-5,659 Reduced 20.47%	21,980 $4.28 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $71,336 - $80,422	-385 Reduced 1.37%	27,639 $5.73 Million
Q2 2018 Jul 09, 2018	SELL	$166.05 - $186.51 $59,279 - $66,584	-357 Reduced 1.26%	28,024 $5.17 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $40,663 - $47,520	-240 Reduced 0.84%	28,381 $4.84 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $36,121 - $40,358	214 Added 0.75%	28,621 $4.98 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $4.75 Million - $5.43 Million	28,407	28,407 $5.3 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.

Account

Thompson Investment Management, Inc. Amgen Inc Transaction History